IMpower150 final overall survival analyses for atezolizumab plus bevacizumab and chemotherapy in first-line metastatic nonsquamous non-small cell lung cancer.
暂无分享，去创建一个
M. Socinski | F. Cappuzzo | D. Moro-Sibilot | F. Barlesi | M. Nishio | M. Mccleland | M. Reck | D. Rodríguez-Abreu | N. Nogami | D. Stroyakovskiy | R. Jotte | W. Zou | G. Finley | F. Orlandi | Christian A Thomas | Anthony Lee | S. Coleman | G. Shankar | S. Kong | C. Thomas | M. McCleland